Literature DB >> 27115053

Mass-forming Intrahepatic Cholangiocarcinoma: Diffusion-weighted Imaging as a Preoperative Prognostic Marker.

Jisun Lee1, Seong Hyun Kim1, Tae Wook Kang1, Kyoung Doo Song1, Dongil Choi1, Kee Taek Jang1.   

Abstract

Purpose To assess the value of diffusion-weighted (DW) imaging as a prognostic marker in preoperative evaluation of patients with mass-forming intrahepatic cholangiocarcinoma (ICC). Materials and Methods This retrospective study was approved by the institutional review board, and the informed consent requirement was waived. A total of 91 patients who underwent hepatic resection and DW imaging for mass-forming ICC were included. Two radiologists evaluated the degree of diffusion restriction of the tumors by using qualitative (visual) interpretation combined with quantitative analysis by volumetric evaluation of the whole tumor on DW images. Patients were classified into two groups: those in whom less than one-third of the tumor showed diffusion restriction (group 1) and those in whom more than one-third of the tumor showed diffusion restriction (group 2). Imaging findings in tumors were compared with pathology findings. Disease-free and overall survival rates were compared between the two groups by using the Kaplan-Meier method with the log-rank test. Results There were 43 patients in group 1 and 48 patients in group 2. The 1- and 3-year disease-free survival rates were 30% and 16%, respectively, in group 1 and 75% and 64%, respectively, in group 2 (P < .001). The 1- and 3-year overall survival rates were 77% and 26%, respectively, in group 1 and 92% and 67%, respectively, in group 2 (P = .001). Multivariate analysis revealed that diffusion restriction (P = .024), differentiation (P = .030), and intrahepatic metastasis (P = .001) were independent prognostic factors for overall survival. Conclusion The degree of diffusion restriction on DW images may be a prognostic marker in preoperative evaluation of patients with mass-forming ICC. (©) RSNA, 2016 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2016        PMID: 27115053     DOI: 10.1148/radiol.2016151781

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

Review 1.  Multimodality imaging of intrahepatic cholangiocarcinoma.

Authors:  Kelly Fábrega-Foster; Mounes Aliyari Ghasabeh; Timothy M Pawlik; Ihab R Kamel
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

2.  Volumetric Histogram Analysis of Apparent Diffusion Coefficient as a Biomarker to Predict Survival of Esophageal Cancer Patients.

Authors:  Atsushi Hirata; Koichi Hayano; Gaku Ohira; Shunsuke Imanishi; Toshiharu Hanaoka; Takeshi Toyozumi; Kentaro Murakami; Tomoyoshi Aoyagi; Kiyohiko Shuto; Hisahiro Matsubara
Journal:  Ann Surg Oncol       Date:  2020-02-25       Impact factor: 5.344

Review 3.  Diffusion MRI of cancer: From low to high b-values.

Authors:  Lei Tang; Xiaohong Joe Zhou
Journal:  J Magn Reson Imaging       Date:  2018-10-12       Impact factor: 4.813

4.  Prediction of the histopathologic findings of intrahepatic cholangiocarcinoma: qualitative and quantitative assessment of diffusion-weighted imaging.

Authors:  Sara Lewis; Cecilia Besa; Mathilde Wagner; Kartik Jhaveri; Shingo Kihira; Hongfa Zhu; Nima Sadoughi; Sandra Fischer; Amogh Srivastava; Eric Yee; Koenraad Mortele; James Babb; Swan Thung; Bachir Taouli
Journal:  Eur Radiol       Date:  2017-12-12       Impact factor: 5.315

5.  Diffusion-weighted imaging as an imaging biomarker for assessing survival of patients with intrahepatic mass-forming cholangiocarcinoma.

Authors:  Julaluck Promsorn; Kulyada Eurboonyanun; Payia Chadbunchachai; Chaiwat Apivatanasiri; Kosin Wirasorn; Jarin Chindaprasirt; Aumkhae Sookprasert; Mukesh Harisinghani
Journal:  Abdom Radiol (NY)       Date:  2022-06-15

6.  Values of MRI Imaging Presentations in the Hepatobiliary Phase, DWI and T2WI Sequences in Predicting Pathological Grades of Intrahepatic Mass-Forming Cholangiocarcinoma.

Authors:  Li-Hong Xing; Li-Yong Zhuo; Jia-Ning Wang; Yan Zhang; Feng-Ying Zhu; Chu Wang; Xiao-Ping Yin; Bu-Lang Gao
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

Review 7.  Intrahepatic cholangiocarcinoma: pathogenesis, current staging, and radiological findings.

Authors:  Mohammed Saleh; Mayur Virarkar; Vlad Bura; Raul Valenzuela; Sanaz Javadi; Janio Szklaruk; Priya Bhosale
Journal:  Abdom Radiol (NY)       Date:  2020-11

Review 8.  Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research.

Authors:  Marcello Mancini; Paul Summers; Francesco Faita; Maurizia R Brunetto; Francesco Callea; Andrea De Nicola; Nicole Di Lascio; Fabio Farinati; Amalia Gastaldelli; Bruno Gridelli; Peppino Mirabelli; Emanuele Neri; Piero A Salvadori; Eleni Rebelos; Claudio Tiribelli; Luca Valenti; Marco Salvatore; Ferruccio Bonino
Journal:  World J Hepatol       Date:  2018-02-27

9.  Added value of diffusion-weighted imaging in hepatic tumors and its impact on patient management.

Authors:  Jana Taron; Jonas Johannink; Michael Bitzer; Konstantin Nikolaou; Mike Notohamiprodjo; Rüdiger Hoffmann
Journal:  Cancer Imaging       Date:  2018-03-07       Impact factor: 3.909

10.  Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features.

Authors:  Michael J King; Stefanie Hectors; Karen M Lee; Olamide Omidele; James S Babb; Myron Schwartz; Parissa Tabrizian; Bachir Taouli; Sara Lewis
Journal:  Cancer Imaging       Date:  2020-07-03       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.